Artelo Biosciences, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-6.1M | $-6.1M | — | $1.5M |
| FY2022 | $-8.0M | $-8.0M | — | $2.5M |
| FY2023 | $-8.2M | $-8.2M | — | $1.0M |
| FY2024 | $-8.4M | $-8.4M | — | $818.0K |
| FY2025 | $-8.5M | $-8.5M | — | $1.1M |